Streetbeat News

Products Services

GM

General Motors (GM) has entered into a supply agreement with Australian resource company Element 25 to secure critical battery minerals for its electric vehicles in North America. GM will receive up to 32,500 tons of manganese sulphate annually from Element 25 over a seven-year period. GM will also loan Element 25 $85 million to aid in the construction of a facility in Louisiana, expected to open in 2025.

Portfolio Pulse from Shivani Kumaresan

June 26, 2023 | 1:01 pm

AVTX

Avalo Therapeutics' shares plummeted by 80% in premarket trading after the Phase 2 PEAK trial of AVTX-002 for non-eosinophilic asthma failed to meet its primary endpoint. However, a positive trend was observed in a subpopulation of patients with high baseline LIGHT levels.

Portfolio Pulse from Vandana Singh

June 26, 2023 | 1:00 pm

JNJ

Johnson & Johnson's Janssen has submitted a Marketing Authorization Application to the European Medicines Agency (EMA) seeking approval for a single tablet combination therapy of Macitentan and Tadalafil for the treatment of patients with Pulmonary Arterial Hypertension.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 12:59 pm

BMMJ

CRLBF

TCNNF

New cannabis experiences are emerging in the US, including cannabis yoga classes, retreats, and new dispensaries. Companies such as Trulieve Cannabis Corp., Cresco Labs Inc., and Body and Mind Inc. are expanding their retail presence.

Portfolio Pulse from Jelena Martinovic

June 26, 2023 | 12:58 pm

BMEA

Biomea Fusion Inc (NASDAQ:BMEA) announced new clinical data from the Phase 2 portion of its ongoing Phase 1/2 clinical study (COVALENT-111) of BMF-219 in type 2 diabetes patients. Patients in Cohorts 2 and 3 showed significant HbA1c reductions. BMEA shares are up 20.60 at $37 during the premarket session.

Portfolio Pulse from Vandana Singh

June 26, 2023 | 12:54 pm

TSM

TSMC is reportedly in talks with potential customers for 2nm chip collaboration, despite unit wafer prices for its 2nm GAA process approaching $25,000, according to sources at IC design houses.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 12:45 pm

FEMY

MEDS

MLTX

MoonLake Immunotherapeutics announced positive results for its Hidradenitis Suppurativa trial, Femasys received FDA approval for its FemBloc Permanent Birth Control IDE, and TRxADE HEALTH issued a correction to its press release on its anticipated combination with Superlatus.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 12:43 pm

ARTL

Artelo Biosciences announced positive preclinical data for its patented cannabidiol (CBD) cocrystal, ART12.11, at the 33rd International Cannabinoid Research Society Symposium. The data showed improved bioavailability and efficacy in nonclinical models of stress-induced anxiety compared to CBD alone, potentially positioning ART12.11 to play a major role in the global anxiety and depression market, estimated to be worth over $11 billion.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 12:43 pm

JAGX

Jaguar Health's Take C.H.A.R.G.E., the first U.S.-based canine cancer registry, has joined the Global Initiative for Veterinary Cancer Surveillance. The registry collects data on canine cancer to guide diagnosis and treatment, and its findings can benefit both human and canine cancer research.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 12:38 pm

VRAR

Brightline Interactive, a subsidiary of The Glimpse Group (NASDAQ:VRAR), has been awarded a low seven-figure Direct-to-Phase II contract with the U.S. Air Force. The company will provide its spatial computing platform, combined with AI and machine learning, to train industrial robots for human-like tasks in operational environments.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 12:37 pm